PI
PBYI icon

Putnam Investments’s Puma Biotechnology PBYI Stock Holding History

Putnam Investments’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,000
Closed -$692K – 1158
2017
Q4 		$692K Sell
7,000
-22,632
-76% -$2.53M ﹤0.01% 938
2017
Q3 		$3.55M Buy
+29,632
New +$2.76M 0.01% 602
2017
Q2 		– Sell
-20,248
Closed -$754K – 1242
2017
Q1 		$754K Buy
20,248
+2,740
+16% +$100K ﹤0.01% 1051
2016
Q4 		$538K Sell
17,508
-596
-3% -$25.8K ﹤0.01% 1111
2016
Q3 		$1.21M Buy
+18,104
New +$915K ﹤0.01% 977
2015
Q2 		– Sell
-45,333
Closed -$10.7M – 1537
2015
Q1 		$10.7M Sell
45,333
-25,742
-36% -$5.5M 0.02% 481
2014
Q4 		$13.5M Sell
71,075
-43
-0.1% -$9.54K 0.03% 419
2014
Q3 		$17M Buy
71,118
+4,930
+7% +$1.01M 0.04% 361
2014
Q2 		$4.37M Buy
66,188
+2,700
+4% +$192K 0.01% 822
2014
Q1 		$6.61M Sell
63,488
-24,538
-28% -$2.88M 0.02% 642
2013
Q4 		$9.11M Sell
88,026
-3,362
-4% -$197K 0.02% 493
2013
Q3 		$4.9M Hold
91,388
– – 0.01% 726
2013
Q2 		$4.05M Buy
+91,388
New +$3.22M 0.01% 791

Other funds holding PBYI

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Putnam Investments's PBYI Position: Q1 2018 in Review

Putnam Investments sold out of Puma Biotechnology (PBYI) in Q1 2018, closing a stake of 7,000 shares — an estimated $692K sold.

Putnam Investments first reported a position in PBYI in Q2 2013 and held it in 13 quarters. The position peaked at $17M in Q3 2014. 178 funds tracked by Wall St. Rank hold PBYI as of Q1 2018.

  • Putnam Investments reported no remaining Puma Biotechnology position as of Q1 2018 after selling out during the quarter.
  • Putnam Investments sold 7,000 Puma Biotechnology shares in Q1 2018, an estimated $692K.
  • Putnam Investments first reported a position in Puma Biotechnology in Q2 2013 and held it in 13 quarters.
  • Putnam Investments's Puma Biotechnology position peaked at $17M in Q3 2014.
  • 178 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2018.

Based on Putnam Investments's 13F filing for Q1 2018, filed 15 May 2018.